| Source Date | Board Meeting Date | Details |
|
21-Mar-2025
|
19-Apr-2025
|
Dividend & Audited Results
|
|
24-Dec-2024
|
25-Jan-2025
|
Quarterly Results
|
|
24-Sep-2024
|
26-Oct-2024
|
Quarterly Results
|
|
25-Jun-2024
|
27-Jul-2024
|
Quarterly Results
|
|
22-Mar-2024
|
27-Apr-2024
|
Final Dividend & Audited Results
|
|
21-Dec-2023
|
20-Jan-2024
|
Quarterly Results
|
|
25-Sep-2023
|
21-Oct-2023
|
Quarterly Results
|
|
22-Jun-2023
|
22-Jul-2023
|
Quarterly Results
|
|
24-Mar-2023
|
22-Apr-2023
|
Audited Results & Final Dividend
|
|
23-Dec-2022
|
21-Jan-2023
|
Quarterly Results
|
|
22-Sep-2022
|
22-Oct-2022
|
Quarterly Results
|
|
24-Jun-2022
|
23-Jul-2022
|
Quarterly Results
|
|
24-Mar-2022
|
23-Apr-2022
|
Audited Results & Final Dividend
|
|
24-Dec-2021
|
22-Jan-2022
|
Quarterly Results
|
|
24-Sep-2021
|
23-Oct-2021
|
Quarterly Results
|
|
28-Jun-2021
|
24-Jul-2021
|
Quarterly Results
|
|
25-Mar-2021
|
24-Apr-2021
|
This is with reference to our earlier letter dated March 25,2021. We wish to inform you that the Board of the Bank at its meeting scheduled on April 24, 2021 will also consider, inter-alia, the following: 'fund raising by way of issuance of debt securities including non-convertible debentures/bonds/notes/offshore certificate of deposits in single/multiple tranches in any currency through public/private placement' We request you to kindly take the above information on record and consider this disclosure as compliance under Regulations 29(1)(d), 50(2) & 50(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
|
|
24-Dec-2020
|
30-Jan-2021
|
Quarterly Results
|
|
30-Oct-2020
|
31-Oct-2020
|
Quarterly Results
|
|
06-Jul-2020
|
08-Jul-2020
|
Inter alia, to consider and approve the proposal of raising funds by issue of equity shares and/or other equity linked securities, through permissiblemode(s) including but not limited to a private placement, preferential issue, qualified institutions placement, further public offer, etc., or any combination thereof, subject to shareholders? approval and regulatory and other approvals as may be required.
|